NTLA Competitors & Alternatives
Compare Intellia Therapeutics Inc with similar stocks in the same industry
Biotechnology
NTLA
Main Stock$12.12
Tradestie Score
51
Market Cap
$2.01B
Revenue Growth
-0.5%
Analyst Upside
+98.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.54
|
$1.81B | - | 74 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$13.91
|
$1.78B | - | 34 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.82
|
$1.78B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$188.05
|
$1.77B | - | 48 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$18.99
|
$1.74B | - | 57 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$32.18
|
$1.68B | - | 59 | Compare |
|
MNKD
Mannkind Corporation
|
$3.95
|
$1.65B | - | 36 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$40.48
|
$1.63B | - | 53 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.14
|
$1.57B | - | 52 | Compare |
|
VCEL
Vericel Corporation
|
$39.44
|
$1.56B | 83.6 | 65 | Compare |
More NTLA Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2835)
230 stocks in this industry